Ryan P Smith

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi request reprint Dosimetric evaluation of radiation exposure during I-125 vicryl mesh implants: implications for ACOSOG z4032
    Ryan P Smith
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA
    Ann Surg Oncol 14:3610-3. 2007
  2. doi request reprint Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation
    Ryan P Smith
    Department of Radiation Oncology, University of Pittsburgh Medical Center, St Maragret s Hospital, 815 Freeport Road, Pittsburgh, PA 15238, USA
    Brachytherapy 7:237-41. 2008
  3. doi request reprint Predictors of urinary morbidity in Cs-131 prostate brachytherapy implants
    Ryan P Smith
    Department of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15238, USA
    Int J Radiat Oncol Biol Phys 81:745-50. 2011
  4. doi request reprint Acute bowel morbidity after prostate brachytherapy with cesium-131
    Bruce L Jacobs
    Department of Urology, University of Pittsburgh School of Medicine, 3471 Fifth Avenue, Pittsburgh, PA 15213 3232, USA
    Brachytherapy 10:51-6. 2011
  5. doi request reprint Clinical and dosimetric factors associated with acute rectal toxicity in patients treated with (131)Cs brachytherapy for prostate cancer
    Abhay S Gokhale
    Department of Radiation Oncology, University of Pittsburgh Medical Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Brachytherapy 9:328-34. 2010
  6. ncbi request reprint Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices
    Than S Kehwar
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, UPMC Cancer Centers, Pittsburgh, Pennsylvania 15232, USA
    Med Phys 36:3536-42. 2009
  7. doi request reprint Influence of prostatic edema on 131Cs permanent prostate seed implants: a dosimetric and radiobiological study
    Than S Kehwar
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, UPMC Cancer Centers, Pittsburgh, Pennsylvania 15232, USA
    Int J Radiat Oncol Biol Phys 80:621-7. 2011
  8. doi request reprint Edema-induced changes in tumor cell surviving fraction and tumor control probability in 131Cs permanent prostate brachytherapy implant patients
    Than S Kehwar
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, UPMC Cancer Centers, Pittsburgh, PA 15232, USA
    J Appl Clin Med Phys 14:3862. 2013
  9. doi request reprint Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131
    Bruce L Jacobs
    Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15232, USA
    Urology 76:1143-7. 2010
  10. doi request reprint Overcoming pubic arch interference with free-hand needle placement in men undergoing prostate brachytherapy
    Erin P Gibbons
    Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Brachytherapy 8:74-8. 2009

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Dosimetric evaluation of radiation exposure during I-125 vicryl mesh implants: implications for ACOSOG z4032
    Ryan P Smith
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA
    Ann Surg Oncol 14:3610-3. 2007
    ..There has been concern that this method exposes physicians and staff to unacceptable amounts of radiation. In this prospective study, we measured the exposure to health care professionals during such a procedure...
  2. doi request reprint Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation
    Ryan P Smith
    Department of Radiation Oncology, University of Pittsburgh Medical Center, St Maragret s Hospital, 815 Freeport Road, Pittsburgh, PA 15238, USA
    Brachytherapy 7:237-41. 2008
    ..This study reports on prostate edema after prostate brachytherapy using Cesium-131 ((131)Cs) and describes our method to compensate...
  3. doi request reprint Predictors of urinary morbidity in Cs-131 prostate brachytherapy implants
    Ryan P Smith
    Department of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15238, USA
    Int J Radiat Oncol Biol Phys 81:745-50. 2011
    ..Cesium-131 is a newer radioisotope being used in prostate brachytherapy (PB). This study was conducted to determine the predictors of urinary morbidity with Cs-131 PB...
  4. doi request reprint Acute bowel morbidity after prostate brachytherapy with cesium-131
    Bruce L Jacobs
    Department of Urology, University of Pittsburgh School of Medicine, 3471 Fifth Avenue, Pittsburgh, PA 15213 3232, USA
    Brachytherapy 10:51-6. 2011
    ..The present study evaluates the severity and time to resolution of bowel symptoms in men undergoing prostate brachytherapy (PB) with cesium-131 ((131)Cs)...
  5. doi request reprint Clinical and dosimetric factors associated with acute rectal toxicity in patients treated with (131)Cs brachytherapy for prostate cancer
    Abhay S Gokhale
    Department of Radiation Oncology, University of Pittsburgh Medical Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Brachytherapy 9:328-34. 2010
    ..131)Cs has been recently introduced for use in prostate brachytherapy. We wished to identify clinical and dosimetric factors associated with acute bowel/rectal toxicity in patients treated with (131)Cs...
  6. ncbi request reprint Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices
    Than S Kehwar
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, UPMC Cancer Centers, Pittsburgh, Pennsylvania 15232, USA
    Med Phys 36:3536-42. 2009
    ..Implants performed based only on the guidance of a preimplant volume study would result in poor dosimetric results for 131Cs implants...
  7. doi request reprint Influence of prostatic edema on 131Cs permanent prostate seed implants: a dosimetric and radiobiological study
    Than S Kehwar
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, UPMC Cancer Centers, Pittsburgh, Pennsylvania 15232, USA
    Int J Radiat Oncol Biol Phys 80:621-7. 2011
    ..To study the influence of prostatic edema on postimplant physical and radiobiological parameters using (131)Cs permanent prostate seed implants...
  8. doi request reprint Edema-induced changes in tumor cell surviving fraction and tumor control probability in 131Cs permanent prostate brachytherapy implant patients
    Than S Kehwar
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, UPMC Cancer Centers, Pittsburgh, PA 15232, USA
    J Appl Clin Med Phys 14:3862. 2013
    ....
  9. doi request reprint Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131
    Bruce L Jacobs
    Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15232, USA
    Urology 76:1143-7. 2010
    ..To evaluate the severity and interval to resolution of the acute lower urinary tract symptoms in men undergoing prostate brachytherapy (PB) with cesium-131 ((131)Cs)...
  10. doi request reprint Overcoming pubic arch interference with free-hand needle placement in men undergoing prostate brachytherapy
    Erin P Gibbons
    Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Brachytherapy 8:74-8. 2009
    ..The present study evaluates the postimplant dosimetry when free-hand needles were placed to overcome interference from the pubic arch...
  11. ncbi request reprint Cesium 131 versus iodine 125 implants for prostate cancer: evaluation of early PSA response
    Jeffrey J Tomaszewski
    Department of Urology, University of Pittsburgh School of Medicine, Pennsylvania, USA
    Can J Urol 17:5360-4. 2010
    ..We compare initial PSA outcomes in men undergoing Cs-131 prostate brachytherapy to men treated with I-125...
  12. doi request reprint PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response
    Dwight E Heron
    University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Am J Clin Oncol 31:352-62. 2008
    ..PET is co-registered with CT and incorporated into a systematic approach to the staging, management, and assessment of response and surveillance of a variety of oncologic diagnoses...
  13. ncbi request reprint Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma
    George van Buren
    Division of Surgical Oncology, UPMC Pancreatic Cancer Center, Pittsburgh, PA, USA
    Ann Surg Oncol 20:3787-93. 2013
    ....
  14. ncbi request reprint Dosimetric outcomes in prostate brachytherapy: is downsizing the prostate with androgen deprivation necessary?
    Erin P Gibbons
    Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA Department of Urology at the University of Toronto, Toronto, Canada
    Brachytherapy 8:304-8. 2009
    ..The present study compares postimplant dosimetry in patients with prostate volumes >50 cc with those with prostate volumes </=50 cc...
  15. pmc Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer
    Athanassios Argiris
    University of Pittsburgh Medical Center Cancer Pavilion, 5th Floor, Pittsburgh, PA 15232, USA
    J Clin Oncol 28:5294-300. 2010
    ..We incorporated cetuximab, a chimeric monoclonal antibody against the epidermal growth factor receptor (EGFR), into the induction therapy and subsequent chemoradiotherapy of head and neck cancer (HNC)...
  16. doi request reprint Prostate-specific antigen spikes with ¹³¹Cs brachytherapy. Is there a difference with other radioisotopes?
    Sushil Beriwal
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Brachytherapy 11:457-9. 2012
    ..There is no published data on the PSA spike with this radioisotope and the goal of this study was to quantify PSA spikes with ¹³¹Cs and compare it with published data for other isotopes...
  17. doi request reprint Prostate brachytherapy after ileal pouch-anal anastomosis reconstruction
    Richard Williamson
    Department of Urology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Urology 73:369-73. 2009
    ..To determine the safety of prostate brachytherapy in patients with clinically localized prostate cancer who have undergone proctocolectomy with ileal pouch-anal anastomosis (IPAA)...
  18. doi request reprint Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: the University of Pittsburgh experience
    Brian T McLaughlin
    Division of Hematology Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15232, USA
    Laryngoscope 120:71-5. 2010
    ..Mucositis and dysphagia are common complications of chemoradiotherapy (CRT) for head and neck cancer that may necessitate nutritional support with a gastrostomy tube (G-tube)...
  19. ncbi request reprint Case report of significant bleeding associated with prostate brachytherapy
    Anthony T Corcoran
    Department of Urology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Can J Urol 16:4682-3. 2009
    ..Prostate brachytherapy is a minimally invasive option in treating prostate cancer, usually with little risk of surgical morbidity. This reports a case of significant bleeding associated with the procedure of prostate brachytherapy...
  20. ncbi request reprint Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT
    Jayakar V Nayak
    Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Laryngoscope 117:2129-34. 2007
    ..To determine whether combined positron emission tomography and computed tomography (PET-CT) may be of value in deferring planned neck dissections for patients with advanced head and neck squamous cell carcinoma (HNSCC)...
  21. ncbi request reprint Modern radiation treatment planning and delivery--from Röntgen to real time
    Ryan P Smith
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, UPMC Cancer Pavilion, 5150 Centre Avenue, Suite 545, Pittsburgh, PA 15232, USA
    Hematol Oncol Clin North Am 20:45-62. 2006
    ..Clinical studies investigating these modalities will likely further increase the efficacy of radiation in years to come...
  22. ncbi request reprint Advances in image-guided radiation therapy--the role of PET-CT
    Dwight E Heron
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, PA 15232, USA
    Med Dosim 31:3-11. 2006
    ..Nevertheless, prospective clinical experience with outcome is encouraged and needs to be expanded to entirely exploit the benefits of the IGRT...
  23. ncbi request reprint Analysis of interfraction and intrafraction variation during tangential breast irradiation with an electronic portal imaging device
    Ryan P Smith
    Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Int J Radiat Oncol Biol Phys 62:373-8. 2005
    ..To evaluate the daily setup variation and the anatomic movement of the heart and lungs during breast irradiation with tangential photon beams, as measured with an electronic portal imaging device...
  24. ncbi request reprint Identification of clinically significant prostate cancer by prostate-specific antigen screening
    Ryan P Smith
    Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Arch Intern Med 164:1227-30. 2004
    ..This study was performed to determine the proportion of clinically significant prostate cancers diagnosed in a screened population...
  25. ncbi request reprint Photodynamic therapy
    Ryan P Smith
    Radiation Oncology, The Hospital of the University of Pennsylvania, USA
    Curr Probl Cancer 26:67-108. 2002